Background and purpose An increasing number of reports have observed thrombosis in
severe cases of COVID-19. The aim of this study was to evaluate the incidence of …

Increasing evidence suggests that COVID-19 may be associated with venous
thromboembolism, and much data exists regarding high incidence of venous thrombosis in …

Abstract Background Coronavirus disease 2019 (COVID‐19) can lead to systemic
coagulation activation and thrombotic complications. Objectives To investigate the incidence …

The COVID-19 pandemic affects more than two million people to date with a high
prevalence of thromboembolic events (TEE) and disseminated intravascular coagulation …

The new coronavirus disease 2019 (COVID-19) pandemic spreads worldwide, provoking
pneumonia, acute respiratory distress syndrome (ARDS) and death. Recently, the medical …

Venous Thromboembolism in Hospitalized COVID-19 Patients : American Journal of
Therapeutics Venous Thromboembolism in Hospitalized COVID-19 Patients : American Journal …

Abstract Coronavirus disease 2019 (COVID-19) is associated with coagulation activation
and high incidence of venous thromboembolism (VTE) in severe patients despite routine …

Background High incidence of asymptomatic venous thromboembolism (VTE) has been
observed in severe COVID‐19 patients, but the characteristics of symptomatic VTE in …

Abstract Background Coronavirus disease (COVID-19) pneumonitis associated with severe
respiratory failure has a high mortality rate. Based on recent reports, the most severely ill …

Background Coagulopathy is a common abnormality in patients with COVID‐19. However,
the exact incidence of venous thromboembolic event is unknown in anticoagulated, severe …